title: Reviewing depot injection efficacy in the treatment of schizophrenia.
abstract: Schizophrenia is a severe and enduring mental health disorder. Treatment includes antipsychotic medication and psychological interventions. Medication can be administered as a depot injection; these treatments reduce the risk of relapse in some people with schizophrenia who have difficulties adhering to oral medication regimens. This article outlines the types of depot and medications that are available for the treatment of schizophrenia, and discusses the evidence base supporting their efficacy. The role of antipsychotic medication as part of a treatment plan should be reinforced by enabling patients to make an informed choice about which medication best supports their health and wellbeing.
authors.affiliation: Betsi Cadwaladr University Health Board, Mold, North Wales.
authors.forename: Adrian
authors.initials: A
authors.lastname: Jones
authors.affiliation: Department of Rural Health, University of South Australia, Whyalla, Australia.
authors.forename: Martin
authors.initials: M
authors.lastname: Jones
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006113:United Kingdom
chemical_list: D014150:Antipsychotic Agents
keywords: adherence; antipsychotic medication; antipsychotics; depot; depot injection; long-acting medication; medicines management; mental health; nurse prescriber; schizophrenia